Advertisement

Topics

Biotech jobs - Biotech, Pharma and Life Science Channel

17:53 EDT 18th September 2018 | BioPortfolio

News Articles [341 Associated News Articles listed on BioPortfolio]

Scientists in our IMED Biotech Unit are combining rigorous neuroscience with drug discovery expertise to evaluate promising new targets for the treatment of neurological diseases, such as the protein KCC2. Read more about their work: http://bit.ly/2MKQHA

Scientists in our IMED Biotech Unit are combining rigorous neuroscience with drug discovery expertise to evaluate promising new targets for the treatment of neurological diseases, such as the protein ...

DOJ Closes Investigation of Sinovac

BEIJING, Sept. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced ...

Scientists from our IMED Biotech Unithave published new research in @nature that can predict and detect off-target effects of #CRISPR #geneediting in vivo. Read more: https://go.nature.com/2xiX5dh pic.twitter.com/ZoWTtxpN2s

Scientists from our IMED Biotech Unithave published new research in @nature that can predict and detect off-target effects of #CRISPR #geneediting in vivo. Read more: https://go.nature.com/2xiX5d...

Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs

Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs Deqing, China, September 17, 2018 / B3C newswire / -- Shuwen...

Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and Nivolumab (Opdivo®) with Standard of Care

CALGARY, Alberta and SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (TSX: ONC) (NASDAQ: ONCY), currently developing REOLYSIN® (pelareorep), an intravenously delivered immu...

Dr Stefan Platz from our IMED Biotech Unit is speaking at #BASELLIFE18. He will be talking about how AstraZeneca is exploring new modalities to rise to the challenge of ‘drugging the undruggable’. Find out more here: http://bit.ly/2ETsoNd  @SJPlatzp

Dr Stefan Platz from our IMED Biotech Unit is speaking at #BASELLIFE18. He will be talking about how AstraZeneca is exploring new modalities to rise to the challenge of ‘drugging the undruggabl...

FIT Biotech Oy: FIT Biotech withdraws a patent application

FIT Biotech Oy                                                                                     ...

LifeMax Appoints Laman Alani, Ph.D., as VP of Product Development

LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating diseases with few or no therapeutic options, today announced the appointment of Laman Alani, Ph.D...

Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"

PRESS RELEASE Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "European Huntington's Disease ...

Are you a #Biotech #Pharma professional? Are you a #Postdoc or Grad #student in #Academia? MIPA is excited to host you ALL 9/28 at @AstraZeneca for our Symp. Meet colleagues from @Amgen @biogen @broadinstitute @Merck @NEBiolabs @Novartis @Pfizer. Register

Are you a #Biotech #Pharma professional? Are you a #Postdoc or Grad #student in #Academia? MIPA is excited to host you ALL 9/28 at @AstraZeneca for our Symp. Meet colleagues from

Events [0 Results]

None

Companies [257 Associated Companies listed on BioPortfolio]

Avayle CTS

Avayle CTS, LLC specializes in the global procurement of commercial drugs for clinical trials worldwide. Pharma and biotech companies rely on the Company’s consultative proje...

Virion Biotherapeutics

Virion Biotherapeutics seeks to transform the management of respiratory viral infections with the development of its proprietary Therapeutic Interfering Particles (TIPs). These fi...

Travecta Therapeutics

Travecta Therapeutics is an emerging biotech company developing a platform that leverages our proprietary knowledge of the MFSD2a transport for the targeted delivery of the...

AcuityBio Inc. and Cook Biotech Inc.

AcuityBio has developed a platform technology for localized, sustained, safe drug-delivery to be used in the prevention of post-surgical lung cancer recurrence. ABC103 combines ap...

Nuvera Life Science Consulting

Nuvera Life Science Consulting helps the world’s leading pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-dis...

LifeMax Laboratories, Inc.

LifeMax Laboratories, Inc. (www.lifemaxlabs.com), a wholly-owned subsidiary of LifeMax Healthcare International Corporation (www.lifemaxhealthcare.com), is a clinical-stage...

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focus...

c-LEcta

c-LEcta is a fully integrated world-leading biotechnology company with focus on enzyme engineering and application in regulated markets like food and pharma. The company is locate...

Hawkins Point Partners

Hawkins Point Partners is a team of dedicated professionals who craft solutions to address their clients' business challenges through the implementation of technology. Although th...

UF Innovate | Sid Martin Biotech

UF Innovate | Sid Martin Biotech is the leading biotechnology incubator headquartered at the University of Florida in Alachua, Florida at Progress Park. Sid Martin has been honore...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

According to recent estimates by the World Health Organization (WHO) on eastern Africa, not all visceral leishmaniasis (VL) cases reported are confirmed by a laboratory test, probably due ...

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Surfactant replacement therapy can be life-saving for newborn infants born with symptomatic lung surfactant deficiency causing Respiratory Distress Syndrome (RDS). Currently, such therapy ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

This phase IV clinical study was designed to evaluate the immunogenicity and safety of the recombinant Hepatitis E vaccine(Hecolin®), manufactured by Xiamen Innovax Biotech CO., LTD., in ...

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Fimaporfin (TPCS2a) is a photosensitiser drug being developed by PCI Biotech AS for use in novel Photochemical Internalisation (PCI) technology. PCI technology is designed to enhance the e...

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

The purpose of this study is to assess the safety and immunogenicity of three seasonal trivalent influenza vaccines (TIVs)manufactured by Glaxosmith Kline (GSK), Beijing Sinovac Biotech (S...

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

This is a bridging trial of the recombinant HPV 16/18 bivalent vaccine manufactured by Xiamen Innovax Biotech CO., LTD.The primary objective of this study is to evaluate the immunogenicity...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant ...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Xenogeneic bone matrix immune risk assessment using GGTA1 knockout mice.

Homeotransplantation of bones for replacement therapy have been demonstrated reliably in clinical data. However, human donor bones applicable for homeotransplantation are in short supply, which facili...

Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade.

Biologics are produced from living organisms in complex, multi-stage manufacturing processes and contain inherent variability, which must be understood and controlled during manufacturing to avoid une...

Structural Dynamics of PET-degrading Cutinase-like Enzyme from Saccharomonospora viridis AHK190 in Substrate-bound States Elucidates Ca Driven Catalytic Cycle.

A cutinase-type polyesterase from Saccharomonospora viridis AHK190 (Cut190) has been shown to degrade the inner block of polyethylene terephthalate. A unique feature of Cut190 is that its function and...

New Nonprofit Biotech From Bill and Melinda Gates.

Second-quarter biotech job picture.

Interaction of substrate-mimicking peptides with the AAA+ ATPase ClpB from Escherichia coli.

A molecular chaperone ClpB disaggregates and reactivates aggregated proteins in cooperation with DnaK, DnaJ, and GrpE. Within a cellular environment, ClpB must distinguish between properly folded and ...

Seed coats as an alternative molecular factory: thinking outside the box.

Seed coats as commodities. Seed coats play important roles in the protection of the embryo from biological attack and physical damage by the environment as well as dispersion strategies. A significant...

Gates unveils biotech-within-a-charity.

Public biotech in 2017-the numbers.

Preformed and induced mechanisms underlies the differential responses of Prunus rootstock to hypoxia.

Analysis of the transcriptomic changes produced in response to hypoxia in root tissues from two rootstock Prunus genotypes differing in their sensitivity to waterlogging: resistant Myrobalan 'P.2175' ...

Videos

None available.

Medical and Biotech [MESH] Definitions

None available.

Advertisement
Quick Search
Advertisement
Advertisement

 
review and buy Biotech jobs market research data and corporate reports here

Channels Quicklinks